Cencora, Inc.NYSE: COR

Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

· Issued by Cencora, Inc. via Business Wire

Summary by 6ix AI

Cencora, a pharmaceutical distribution and services company, plans to release its results for the third quarter of fiscal 2026 on Wednesday, August 5, 2026, before trading opens on the New York Stock Exchange, and will hold a conference call to discuss them at 8:30 a.m. ET that day.

Key details

  • President and CEO Robert P. Mauch and Executive Vice President and CFO Eva C. Boratto will take part in the call.
  • The call will be webcast live on the company's investor website, and a replay will be posted approximately one hour after the call and remain available for one year.

6ix AI wrote this summary from the release below and checked it against the release.

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026.

Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
Eva C. Boratto, Executive Vice President & Chief Financial Officer

The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.

To access the call via telephone from within the United States and Canada, dial +1 (833) 461-5787. From outside the United States and Canada, dial +1 (585) 542-9983. The meeting ID for the call will be 632 369 927.

A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year.

Please check the website investor.cencora.com for updates regarding the timing of the live webcasts and for replay information.

About Cencora

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #17 on the Global Fortune 500 with more than $300 billion in annual revenue. Learn more at investor.cencora.com.

View original source (Business Wire)Cencora, Inc. on 6ix

Story so far

Earlier from Cencora

Later from Cencora

All Cencora news releases